- AXDX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
Accelerate Diagnostics (AXDX) S-1IPO registration
Filed: 13 Dec 23, 5:30pm
Exhibit 107.1
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
ACCELERATE DIAGNOSTICS, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount to be Registered | Proposed Maximum Offering Price Per Unit | Proposed Maximum Aggregate Offering Price(1)(2) | Fee Rate | Amount of Registration Fee(3) | Carry Forward Form Type | Carry Forward File Number | Carry Forward Initial effective date | Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward |
Equity | Units, consisting of | Rule 457(o) | — | — | $20,000,000 | $0.00014760 | $2,952 | ||||
Equity | (i) Common Stock, par value $0.001 per share | Rule 457(i) | — | — | — | — | — | ||||
Equity | (ii) Warrants to purchase Common Stock | Rule 457(i) | — | — | — | — | — | ||||
Equity | Pre-Funded Units consisting of:(3) | — | — | — | — | — | — | ||||
Equity | (i) Pre-Funded Warrants to purchase Common Stock | Rule 457(i) | — | — | — | — | — | ||||
Equity | (ii) Warrants to purchase Common Stock | Rule 457(i) | — | — | — | — | — | ||||
Equity | Common stock issuable upon exercise of the Warrant | Rule 457(o) | — | — | $20,000,000 | $0.00014760 | $2,952 | ||||
Equity | Common Stock issuable upon exercise of the Pre- Funded Warrants(3) | — | — | — | — | — | — | ||||
Total Offering Amounts | $40,000,000 | $5,904 | |||||||||
Total Fees Previously Paid | — | ||||||||||
Total Fee Offsets | — | ||||||||||
Net Fee Due | $5,904 |
(1) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
(2) | Pursuant to Rule 416(a) under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from stock splits, stock dividends or similar transactions. |
(3) | The proposed maximum aggregate offering price of the Units proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the Pre-Funded Units offered and sold in the offering (plus the aggregate exercise price of the common stock issuable upon exercise of the Pre-Funded Warrants) |